Opiate Addiction, Pharmacological Treatment Approaches CO-OCCURRING MENTAL HEALTH DISORDERS JOSEPH A. BEBO MA, CAGS, LADC1
|
|
- Grant Robbins
- 2 years ago
- Views:
Transcription
1 Opiate Addiction, Pharmacological Treatment Approaches CO-OCCURRING MENTAL HEALTH DISORDERS JOSEPH A. BEBO MA, CAGS, LADC1
2 Disclosure Statement
3 Prevalence of Opioid Addiction 100 Individuals Die Every Day according to ONDCP whitehouse.org Die Across the Country In Massachusetts In New England In The Nations High Schools
4 Factors Influence Prevalence of Substance Use Disorders: Client Characteristics Higher Rates Males Family History of SUD Younger Antisocial Personality Disorders Lower Education Level Childhood Conduct Disorders Single or Never Married Homelessness Emergency Rooms High Affective Symptomology Jails Acute Psychiatric Hospitals Urban Setting / Recent Increases Rural Settings
5 Clinical Correlates Relapse and Re-hospitalization Violence Housing Instability Legal Problems Family Stress Money / Financial Problems Medical Problems: Infectious Disease Demoralization: Suicide
6 Myths of Medication Treatments 1 st : Medication are not really part of treatment 2 nd : Medications are drugs and you cannot be clean if you are taking anything 3 rd Medications are a crutch that impedes recovery 4 th Medication will get you high 5 th The self-help literature has a position against the use of medications
7 Patient Screen and Assessment COWS (Clinical Opiate Withdrawal Scale) Wesson et al, 1999 SOWS ( Subjective Opiate Withdrawal Scale) Brdley et al, 1987; Handlesman et al, 1987; Gossip 1990 Narcotic Withdrawal Scale (Fultz & Senal, 1975) CINA (Clinical Institute Narcotic Assessment Scale for Withdrawal Symptom) Peachey & Lei 1988 DAST (Drug Abuse Screening Test) Skinner 1988 URINE CONFIRMATORY TEST
8 Basic Neuro Transmitters Dopamine Serotonin GABA / Glutamate Norepinephrine Endogenous Opioids / Mu Receptors Acetylcholine
9 Medications for Assisted Treatment Changes Since Drug Abuse Treatment Act of 2000 Buprenorphine: Partial Agonist Acamprosate: Reduces Cravings Naltrexone: Agonist Antabuse / Disulfiram Methadone / Long Acting Methadone(LAAM) Levo-alpha-acetyl-methadol
10 Buprenorphine / Suboxone/ Subutex / Vivitrol Detoxification / Medication Assisted Withdrawal Multi-Phase Program Induction / Objective Stabile rapidly; Minimize Withdrawal Symptom; Eliminate Further Opiate Use A short Period ( 3 days) A moderate Period (10 to 14 days, Reduce 2mg every 2 or 3 days) A Long Period Stabilization: No Withdrawal; Minimal Side Effects; No Uncontrollable Crave Maintenance: Relatively Short; One Year; Two Years; Indefinite
11 Four Supports of Treatment Spiritual Psychological Biological Social If you consider a square table as representing treatment you need all four legs for supports to stabilize treatment: therefore the client without one of the supports like the table becomes unstable
12 Attributes of Effective Provider Ability to establish Helping Alliance / Trust Good Interpersonal Skills / Non Judgmental Friendliness / Genuineness Respect / Affirmation Patient Centered / Supportive Style Reflective Listening / Empathy
13 Holistic Approach Regardless of the type of therapeutic intervention, a treatment plan needs to be tailored to the individual client addressing all of the needs presented not just the drug addiction Homelessness Employment Circumstance Family involvement ADL Needs Child Care Issues Co- Occurring disorders Legal Issues Religious Beliefs Learning Disability Cultural Identity and Norms Physical Disability Developmental Disability Needs Associated with Learning, Physical, and Developmental Issues.
14 Integrated Treatment Mental Health and Substance Misuse and Dependence Treatment Needs to be delivered Concurrently By the same treatment team or group of clinicians including cooperative prescriber Delivery should occur within the same program and facility when possible The majority of the burden is upon the clinicians to determine if treatment plan is effective or needs adjustment
15 Comprehensive Treatment Focus Not Only On Substance Misuse Pharmacological Treatments Rehabilitation / Habilitation to address: Social Needs Coping Skills Leisure & Recreation Role Functioning Attention To Housing, Legal Problems, Family Relationships
16 Reduction of Harmful Consequences Severe Outcomes Are Common Reduction of Harmful Consequences Engages Client in Treatment Improvement Often Occurs Through Gradual Reduction of Substance Use Maintain Focus On Health and Housing Issues Family Involvement for Support to Minimize Loss of Housing
17 Features of Integrated Treatment Stage-wise Approach: Engagement, Persuasion, Active Treatment, and Relapse Prevention Treatment must be comprehensive / Case Management Characteristics Long Term Commitment / Plan to reduce Negative Consequences Facilitate engagement of family & friends or partners When necessary include outreach to engage the client
18 Stages of Treatment Engagement, Persuasion, Active Treatment, and Relapse Prevention Treatment is Not Linear Stage of Treatment Determines Goals Goals established with Client Determine Intervention Multiple Option at Each Stage are Possible
19 What to Do During Engagement? Goal : To Establish a Working Alliance with the Client Clinical Strategies to Employ Outreach Practical Assistance Social Network Support Legal Constraints Perceived as Hindrance Crisis Intervention
20 What to do During Persuasion? Goal: To Motivate Client to Address the Substance Abuse as a Major Problem Clinical Strategies Stabilization: Pharmacological and Psychiatric Psychoeducation: Family and Individual Rehabilitation: Physical, Nutritional, etc. Motivational Interviewing Education: Areas of Deficit
21 What to do During Active Treatment? Goal: To Reduce Clients Use/ Abuse of Substances Clinical Strategies Self-Monitoring Social Skills Training / Habilitation Social Network Interventions / Develop Healthy Relations Self-Help Groups / NA, AA, Smart, etc. / Substitute Activities Close Monitoring Cognitive Behavioral Techniques to Address: High Risk Situations, Cravings, Motives for Substance Use; Socialization, Persistent Symptoms, Pleasure Enhancement
22 What Do You Do During Relapse Prevention? Goal: To Maintain Awareness of Vulnerability and Expand Recovery to Other Areas Clinical Strategies Self Help Groups / Substitutes Cognitive-Behavioral or/and Supportive Interventions to Enhance Functioning in areas such as work, relationships, leisure activities, health, and overall quality of life.
23 Long Term Perspective Mental Illness and Substance Misuse and Dependence are both Chronic Relapsing Disorders Long Term Treatment is Required for Both Disorders Settings Specific Criteria for Treatment Goals Early Assists with Reduction of Medications for Substance Misuse Expectations Should Include a Non-Linear Perspective Never Give Up on Client That is What they expect.
24 Conclusions Substance Use Disorders are Common to Severe Mental Illness and Contribute to Worse Outcomes Especially with Opioid Addiction Integrated Treatment Models Treat Both Disorders Concurrently & Employ Motivation Based, Comprehensive Interventions Research on Integrated Treatment Provides Substantial Evidence Supporting its Effect to Improve Substance Misuse Outcomes
25 REFERENCES
Opioid Treatment Services, Office-Based Opioid Treatment
Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,
Topics In Addictions and Mental Health: Concurrent disorders and Community resources. Laurence Bosley, MD, FRCPC
Topics In Addictions and Mental Health: Concurrent disorders and Community resources Laurence Bosley, MD, FRCPC Overview Understanding concurrent disorders. Developing approaches to treatment Definitions
SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK
National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal
Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
Questions to Ask Each Rehab Facility. Includes Notes and Recommendations
Questions to Ask Each Rehab Facility Includes Notes and Recommendations Finding the right rehab can be grueling. Admissions personnel are there to convince you that their program is the best. It is your
Minnesota Co-occurring Mental Health & Substance Disorders Competencies:
Minnesota Co-occurring Mental Health & Substance Disorders Competencies: This document was developed by the Minnesota Department of Human Services over the course of a series of public input meetings held
Patients are still addicted Buprenorphine is simply a substitute for heroin or
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute
Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community
Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community Dr David Jackson Clinic Medical Officer The Hobart Clinic Association Drugs In tonight s context, drugs
Today s Topics. Session 2: Introduction to Drug Treatment. Treatment matching. Guidelines: where should a client go for treatment?
Session 2: Introduction to Drug Treatment Today s Topics Level of care determination How to know when treatment works What does treatment include Description of treatment modalities Naomi Weinstein, MPH
Using Drugs to Treat Drug Addiction How it works and why it makes sense
Using Drugs to Treat Drug Addiction How it works and why it makes sense Jeff Baxter, MD University of Massachusetts Medical School May 17, 2011 Objectives Biological basis of addiction Is addiction a chronic
Treating Co-Occurring Disorders. Stevie Hansen, B.A., LCDC, NCACI Chief, Addiction Services
Treating Co-Occurring Disorders Stevie Hansen, B.A., LCDC, NCACI Chief, Addiction Services Implementing SAMHSA Evidence-Based Practice Toolkits Integrated Dual Diagnosis Treatment (IDDT) Target group:
TREATMENT MODALITIES. May, 2013
TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.
Beyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
Outline. Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction
Outline Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction About Substance Abuse The Cost of Chemical Abuse/Addiction Society's Response The Continuum of Chemical Use Definitions of Terms
CLINICAL POLICY Department: Medical Management Document Name: Vivitrol Reference Number: NH.PHAR.96 Effective Date: 03/12
Page: 1 of 7 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted
Opiate Abuse and Mental Illness
visited on Page 1 of 5 LEARN MORE (HTTP://WWW.NAMI.ORG/LEARN-MORE) FIND SUPPORT (HTTP://WWW.NAMI.ORG/FIND-SUPPORT) GET INVOLVED (HTTP://WWW.NAMI.ORG/GET-INVOLVED) DONATE (HTTPS://NAMI360.NAMI.ORG/EWEB/DYNAMICPAGE.ASPX?
SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK
National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal
Evidence Based Approaches to Addiction and Mental Illness Treatment for Adults
Evidence Based Practice Continuum Guidelines The Division of Behavioral Health strongly encourages behavioral health providers in Alaska to implement evidence based practices and effective program models.
UNDERSTANDING CO-OCCURRING DISORDERS. Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015
UNDERSTANDING CO-OCCURRING DISORDERS Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015 CO-OCCURRING DISORDERS What does it really mean CO-OCCURRING
Buprenorphine Therapy in Addiction Treatment
Buprenorphine Therapy in Addiction Treatment Ken Roy, MD, FASAM Addiction Recovery Resources, Inc. River Oaks Hospital Tulane Department of Psychiatry www.arrno.org Like Minded Doc What is MAT? Definition
Care Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
Use of Pharmacotherapies by Substance Abuse Treatment Facilities
Use of Pharmacotherapies by Substance Abuse Treatment Facilities Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration Department of Health and Human Services November 2007 1
Group Intended Participant Locations Cost Curriculum Length. Longmont & Boulder. Longmont & Boulder
County Public Health ADDICTION RECOVERY CENTERS (ARC) www.countyarc.org We offer some of the best evidence-based outpatient treatment services for men, women, and teens in the State of Colorado. We offer
Alcohol intervention programs in other countries
Alcohol intervention programs in other countries Assist. Prof. Dr. Suttiporn Janenawasin Siriraj Hosp. Mahidol Univ. A Major Task for Drug Treatment is Changing Brains Back! The Most Effective Treatment
information for service providers Schizophrenia & Substance Use
information for service providers Schizophrenia & Substance Use Schizophrenia and Substance Use Index 2 2 3 5 6 7 8 9 How prevalent are substance use disorders among people with schizophrenia? How prevalent
Co-Occurring Substance Use and Mental Health Disorders. Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs
Co-Occurring Substance Use and Mental Health Disorders Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs Introduction Overview of the evolving field of Co-Occurring Disorders Addiction and
OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines
OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines Guideline Evaluation and Treatment Planning Discharge Planning Admission Criteria Continued Stay Criteria Discharge
The Use of Non-Opioid Pharmacotherapies. for the Treatment of Alcohol Dependence
M00K02 Alcohol and Drug Abuse Administration Department of Health and Mental Hygiene The Use of Non-Opioid Pharmacotherapies for the Treatment of Alcohol Dependence Introduction The 2011 Joint Chairmen
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction James H. Barger, MD SAPC Medical Director and Science Officer Desiree A. Crevecoeur-MacPhail, Ph.D.
ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines
MEDICAL ASSISTANCE BULLETIN
ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical
2015 OPIOID TREATMENT PROGRAM DESCRIPTIONS
2015 OPIOID TREATMENT PROGRAM PROGRAM DESCRIPTIONS Contents Opioid T reatment Program Core Program Standards... 2 Court Treatment (CT)... 2 Detoxification... 2 Day Treatment... 3 Health Home (HH)... 3
Web-Based Resources. Locating Treatment
Web-Based Resources Locating Treatment http://dpt2.samhsa.gov/treatment/ -- This is the Substance Abuse and Mental Health Services Administration s (SAMHSA) page for locating both public and private opiate
EPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months
Presented by. 13 Principles 10/27/09. Principles of Drug Addiction Treatment: A Research Based Guide
Presented by Principles of Drug Addiction Treatment: A Research Based Guide Rick Moldenhauer, MS, LADC, ICADC, LPC Treatment Services Consultant, Alcohol and Drug Abuse Division PO Box 64977, St Paul,
In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.
Vivitrol Pilot Study: SEMCA/Treatment Providers Collaborative Efforts with the treatment of Opioid Dependent Clients Hakeem Lumumba, PhD, CAADC SEMCA Scott Schadel, MSW, LMSW, CAADC HEGIRA PROGRAMS, INC.
Working with young people who have mental health and substance use issues. Samar Zakaria
Working with young people who have mental health and substance use issues. Samar Zakaria Main points Challenges faced while treating young adults in a dual diagnosis rehab unit Define dual diagnosis in
DrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
Opioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
Schizoaffective Disorder
FACT SHEET 10 What Is? Schizoaffective disorder is a psychiatric disorder that affects about 0.5 percent of the population (one person in every two hundred). Similar to schizophrenia, this disorder is
Health Care Service System in Thailand for Patients with Alcohol Use Disorder
Health Care Service System in Thailand for Patients with Alcohol Use Disorder Health Care Service System In Thailand Screening for alcohol use disorder and withdrawal syndrome AUDIT MAST CAGE CIWA or AWS
Evidence Based Practice in the Treatment of Addiction Treatment of Addiction. Steve Hanson
Evidence Based Practice in the Treatment of Addiction Treatment of Addiction Steve Hanson History of Addiction Treatment Incarceration Medical Techniques Asylums What We Learned These didn t work Needed
Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft***
Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft*** This content, sorted by LCME competencies is intended to
Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES
01736 850006 www.bosencefarm.co.uk DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES An environment for change Boswyns provides medically-led drug and alcohol assessment, detoxification and stabilisation.
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
Non medical use of prescription medicines existing WHO advice
Non medical use of prescription medicines existing WHO advice Nicolas Clark Management of Substance Abuse Team WHO, Geneva Vienna, June 2010 clarkn@who.int Medical and Pharmaceutical role Recommendations
Various therapies are used in the
National Survey of Substance Abuse Treatment Services The N-SSATS Report January 28, 2010 Overview of Opioid Treatment Programs within the United States: 2008 In Brief In 2008, a total of 1,132 (8 of all
Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis
The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,
MEDICAL ASSISTANCE BULLETIN
ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy
Frequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
Congressional Testimony. Laurence M. Westreich, M.D. President, American Academy of Addiction Psychiatry
Congressional Testimony Laurence M. Westreich, M.D. President, American Academy of Addiction Psychiatry Combatting the Opioid Abuse Epidemic: Professional and Academic Perspectives, April 23 rd 2015 Subcommittee
NEW HAMPSHIRE CODE OF ADMINISTRATIVE RULES. PART He-W 513 SUBSTANCE USE DISORDER (SUD) TREATMENT AND RECOVERY SUPPORT SERVICES
CHAPTER He-W 500 MEDICAL ASSISTANCE PART He-W 513 SUBSTANCE USE DISORDER (SUD) TREATMENT AND RECOVERY SUPPORT SERVICES He-W 513.01 Purpose. The purpose of this part is to establish the procedures and requirements
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
MEDICATION ASSISTED TREATMENT (MAT)
MEDICATION ASSISTED TREATMENT (MAT) STATISTICS: ALCOHOL AND OPIOID USE Last year 33 Iowans died from opioid overdose deaths; an additional 19 individuals died of a heroin overdose. The number of drug overdose
12 Steps to Changing Neuropathways. Julie Denton
12 Steps to Changing Neuropathways Julie Denton Review the neurobiology of the brain Understand the basics of neurological damage to the brain from addiction Understand how medications and psychotherapy
Resources for the Prevention and Treatment of Substance Use Disorders
Resources for the Prevention and Treatment of Substance Use Disorders Table of Contents Age-standardized DALYs, alcohol and drug use disorders, per 100 000 Age-standardized death rates, alcohol and drug
Allyse Adams PC, LICDC Oriana House, Inc.
Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In
2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California
2015 OPSC Annual Convention syllabus February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California FRIDAY, FEBRUARY 6, 2015: 9:30am - 10:30am Opioid Addiction and Buprenorphine Use * Presented by
Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD)
Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD) Learning Objectives Upon completion of this module, you should be able to: Describe how
Advanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation
Advanced Treatment for Opioid & Alcohol Dependence John Larson, M.D. Corporate Medical Director Gateway Foundation Background 41 years practicing psychiatry Last 15 in addiction medicine I ve watched a
MOVING TOWARD EVIDENCE-BASED PRACTICE FOR ADDICTION TREATMENT
MOVING TOWARD EVIDENCE-BASED PRACTICE FOR ADDICTION TREATMENT June, 2014 Dean L. Babcock, LCAC, LCSW Associate Vice President Eskenazi Health Midtown Community Mental Health Centers Why is Evidence-Based
Co-Occurring Disorders
Co-Occurring Disorders PACCT 2011 CAROLYN FRANZEN Learning Objectives List common examples of mental health problems associated with substance abuse disorders Describe risk factors that contribute to the
Mental Health and Addiction Services Overview
Mental Health and Addiction Services Overview CEAC 0216 January 2015 Mental Health and Addiction Services Management Team Executive Director (306) 766-7930 Manager, Rural Mental Health & Addictions (306)
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the
THE BASICS. Community Based Medically Assisted Alcohol Withdrawal. World Health Organisation 2011. The Issues 5/18/2011. RCGP Conference May 2011
RCGP Conference May 2011 Community Based Medically Assisted Alcohol Withdrawal THE BASICS An option for consideration World Health Organisation 2011 Alcohol is the world s third largest risk factor for
4.401 Substance Use Partial Hospitalization Program (Adults and Adolescents)
4.40 STRUCTURED DAY TREATMENT SERVICES 4.401 Substance Use Partial Hospitalization Program (Adults and Adolescents) Description of Services: Substance use partial hospitalization is a nonresidential treatment
The Heroin Epidemic in Adolescents and Young Adults. Marla D. Kushner, DO, FACOFP, FASAM, FSAHM AOAAM February 25, 2015
The Heroin Epidemic in Adolescents and Young Adults Marla D. Kushner, DO, FACOFP, FASAM, FSAHM AOAAM February 25, 2015 1 Marla Kushner, DO, Disclosures Speaker Bureau Alkermes Reckitt Benckiser 2 TARGET
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
Integrated Treatment for Co-Occurring Disorders
Integrated Treatment for Co-Occurring Disorders An Evidence-Based Practice What Are Evidence-Based Practices? Services that have consistently demonstrated their effectiveness in helping people with mental
Medications Used in the Treatment of Addiction Developed by Randall Webber, MPH. Alcohol Withdrawal
Medications Used in the Treatment of Addiction Developed by Randall Webber, MPH Alcohol Withdrawal MEDICATION Long/intermediateacting benzodiazepines (e.g., chlordiazepoxide/ Librium, diazepam/valium)
Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
Corl Kerry - Referral and Assessment for Residential Treatment (Tier 4) Introduction Types of Tier 4 Services Services provided at Tier 4
Corl Kerry - Referral and Assessment for Residential Treatment (Tier 4) This document seeks to name the criteria that can guide referrals to residential tier 4 facilities (Part A). It provides guidance
Clinical Training Guidelines for Co-occurring Mental Health and Substance Use Disorders
Winnipeg Region Co-occurring Disorders Initiative Clinical Training Guidelines for Co-occurring Mental and Substance Use Disorders September 2003 Clinical Training Guidelines for Co-occurring Mental and
Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.
Addiction Psychiatry Program Site Specific Goals and Objectives Addiction Psychiatry (ADTU) Goal: By the end of the rotation fellow will acquire the knowledge, skills and attitudes required to recognize
Naltrexone and Alcoholism Treatment Test
Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score
SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011
SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011 This document is intended to be used with the Somerset Dual Diagnosis Operational Working guide. This document provides principles governing joint working
Opiate Addiction and the Prescription Drug Crisis. Paul Updike, MD Medical Director of Chemical Dependency Services, Catholic Health System
Opiate Addiction and the Prescription Drug Crisis Paul Updike, MD Medical Director of Chemical Dependency Services, Catholic Health System Objectives Define what addiction is Describe what opiates are
Treatment Resources for Substance Use Disorders
Treatment Resources for Substance Use Disorders The treatment of substance use disorders can be very complex; there are many levels of care and the treatment network can be challenging to navigate. Substance
OASAS (Office of Alcoholism and Substance Abuse Services) Prevention and Treatment Services in Albany County. Albany County OASAS Prevention Providers
OASAS (Office of Alcoholism and Substance Abuse Services) Prevention and Treatment Services in Albany County Albany County OASAS Prevention Providers The Addiction Care Center (ACCA) -Prevention and Community
LEVEL III.5 SA: SHORT TERM RESIDENTIAL - Adult (DUAL DIAGNOSIS CAPABLE)
LEVEL III.5 SA: SHT TERM RESIDENTIAL - Adult (DUAL DIAGNOSIS CAPABLE) Definition The following is based on the Adult Criteria of the Patient Placement Criteria for the Treatment of Substance-Related Disorders
LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult
LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult Definition The following is based on the Adult Criteria of the Patient Placement Criteria for the Treatment of Substance-Related Disorders of the American
Update and Review of Medication Assisted Treatments
Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
Addiction: Disease or Choice?
Addiction: Disease or Choice? Presented by Michael Coughlin RN October 18, 2012 Introduced by Melanie Willows B.Sc. M.D. C.C.F.P. C.A.S.A.M. C.C.S.A.M. Assistant Professor University Of Ottawa Clinical
Treatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES
Course Description SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES At the end of this course participants will be able to: Define and distinguish between substance use, abuse and dependence
Increasing Issues of Polypharmacy and Off-Label Drug Use in Psychiatric Care
Increasing Issues of Polypharmacy and Off-Label Drug Use in Psychiatric Care Stefan P. Kruszewski, MD Board Certified in Adult, Geriatric, Adolescent and Addiction Psychiatry, and Addiction Medicine Speaker
Joel Millard, DSW, LCSW Dave Felt, LCSW
Joel Millard, DSW, LCSW Dave Felt, LCSW 1. Provide an overview of the effectiveness of medication assisted treatment, to include a discussion of the different types of medications and how they are used
SUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12
SUBOXONE /VIVITROL WEBINAR Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12 WEBINAR INTRODUCTIONS Cynthia Parsons- Program Manager
Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
Medical Necessity Criteria
Medical Necessity Criteria 2015 Updated 03/04/2015 Appendix B Medical Necessity Criteria Purpose: In order to promote consistent utilization management decisions, all utilization and care management staff
MAT Counselor Education Course Exam Questions Packet Part 1
MAT Counselor Education Course Exam Questions Packet Part 1 Course No: Course Title: Course Objective: MA-1901P1 Medication-Assisted Treatment (MAT) Counselor Education Course Part 1 Includes primer on
Performance Standards
Performance Standards Co-Occurring Disorder Competency Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best
ABOUT US. and Expressive Therapy (Dance/Movement, Art, Drama) in addition to individual, group and family therapy by skilled therapists.
ABOUT US n Riveredge Hospital maintains the treatment philosophy of Trauma Informed Care. n Our commitment to providing the highest quality of care includes offering Animal Assisted Therapy, and Expressive
opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380
opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100
Produced and Published by The Cabin Chiang Mai, Alcohol and Drug Rehab Centre. Copyright 2013. and How is it Treated?
and How is it Treated? 1 About this book This E-book has been produced as a guide to help explain some of the fundamental things you need to understand about addiction and its treatment, starting with
Scope of Services provided by the Mental Health Service Line (2015)
Scope of Services provided by the Mental Health Service Line (2015) The Mental Health Service line provides services to Veterans with a wide variety of mental health needs at its main facility in Des Moines